Related Experiment Video

Updated: Apr 16, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.4K

Cellular plasticity and heterogeneity underlying therapy resistance in 3D cervical cancer models

Mercedes Olvera-Valencia1,2, Adriana Grijalva-Pérez3,4, Oliver Millan-Catalan5

  • 1Subdirección de Investigación Básica, Laboratorio de Virus y Cáncer, Instituto Nacional de Cancerología, Mexico City, 14080, Mexico.

Hereditas
|April 14, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
3D culturesCervical cancerDrug testing

More Related Videos

Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture
07:44

Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture

Published on: June 23, 2020

12.7K
Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
09:18

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Published on: April 4, 2025

1.4K

Related Experiment Videos

Last Updated: Apr 16, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.4K
Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture
07:44

Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture

Published on: June 23, 2020

12.7K
Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
09:18

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Published on: April 4, 2025

1.4K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K

Articles linked to this work by shared authors, journal, and citation graph.

HOTAIR at the metabolic crossroads: lncRNA control of carbohydrate and lipid metabolism.

Epigenomics·2026

miR-195 and miR-549a Are Essential Biomarkers for Early-Onset Colorectal Cancer.

International journal of molecular sciences·2026

[Retracted] Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF‑7 breast cancer cells.

International journal of oncology·2025

The role of complementary lymphadenectomy in patients with incidental endometrial cancer.

Frontiers in oncology·2025

Long noncoding RNAs involved in therapeutic response: implications for cervical cancer drug resistance.

Frontiers in oncology·2025

Polyphenols bind G4-Quadruplex structures and act as epigenetic modifiers with anti-cancer effects.

EXCLI journal·2025

Targeting RASL12 by miR-6791-5p fuels malignant progression in lung adenocarcinoma.

Hereditas·2026

Haplotype-based validation of genomic regions for breeding of new Nordic apples.

Hereditas·2026

miR-335-3p acts as a tumor suppressor in esophageal squamous cell carcinoma and predicts favorable prognosis.

Hereditas·2026

SNP rs7430456 mediated LINC00578 drives triple negative breast cancer through regulating miR-143-5p expression.

Hereditas·2026

BFLF1 gene polymorphisms are associated with increased mortality in patients with EBV-associated diseases.

Hereditas·2026

miR-1-3p, as a novel diagnostic and prognostic biomarker, aggravates pancreatic acinar cell injury in acute pancreatitis by targeting GNPTAB.

Hereditas·2026

Margin-enriched CD4+ central-memory T cells affect macrophages via ANXA1-FPR1 signaling axis to promote tumor progression in intrahepatic cholangiocarcinoma.

International journal of biological sciences·2026

Mapping the Evolutionary Landscape of Solid Tumor Immunotherapy: A Quarter-Century Bibliometric Analysis of the Title-Defined Core Literature (2000-2025).

International journal of medical sciences·2026

Decoding Pancreatic Cancer Pain: From Tumor-Nerve Crosstalk to Targeted Analgesic Strategies.

International journal of medical sciences·2026

Urinary microbiota in bladder cancer: insights into pathogenesis, diagnosis, and therapeutic potential.

Frontiers in cellular and infection microbiology·2026

Obstructive Sleep Apnoea and Atrial Fibrillation: Current Evidence and Emerging Research Directions.

Reviews in cardiovascular medicine·2026

The subcellular localization-dependent dual role of NR4A1 in renal fibrosis: mechanisms and therapeutic perspectives.

Frontiers in pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us